Alzheimer's disease (AD) is the most common form of dementia. The main pathological hallmark associated with the disease is the presence of senile plaques that are composed of amyloid beta peptide (Aβ). This peptide is a key component in disease pathology and is thought to underlie neuronal loss seen in AD brains. Recent evidence now suggests a physiological role for the peptide in the maintenance of neuronal excitability. At physiological concentrations of Aβ (10 nM), we have previously demonstrated the modulation of Kv4.2 channels. In the present study we investigated both the physiological and the pathological concentrations of Aβ that contains 40 amino acid residues (Aβ 1-40), and determined its effects on Kv4.2 channels. Aβ1-40 was tox...
A current hypothesis for the pathology of Alzheimer's disease (AD) proposes that amyloid-beta (A[bet...
AbstractAlzheimer's disease (AD) is associated with impaired glutamate clearance and depressed Na+/K...
Astrocyte dysfunction emerges early in Alzheimer's disease (AD) and may contribute to its pathology ...
Altered neuronal excitability is emerging as an important feature in Alzheimer's disease (AD). Kv2.1...
Amyloid beta (Aβ) accumulation plays an important role in the pathogenesis of Alzheimer's disease (...
Previous studies have shown that amyloid $\beta$-peptide (A$\beta$P), a normally secreted protein fo...
Alzheimer’s disease (AD) is a progressive and irreversible brain disorder which results in memory lo...
ABSTRACT: Tau is a microtubule associated protein implicated in the pathogenesis of several neurodeg...
The aim of the present study was to investigate whether K(V)3.4 channel subunits are involved in neu...
Alzheimer’s disease (AD) is the most common neurodegenerative disorder and the first cause of dement...
Aβ deposition is a pathological hallmark of Alzheimer's disease (AD). Besides the full-length amyloi...
Alzheimer’s disease (AD) is a neurodegenerative disorder characterized by the progressive deteriorat...
The prevailing hypothesis for pathology of Alzheimer's disease (AD) proposes that amyloid-beta (A[Be...
Alzheimer’s disease is characterized by a marked dysregulation of intracellular Ca2+ homeostasis. In...
Deposition of beta-amyloid peptide (A beta) in senile plaques is a hallmark of Alzheimer disease neu...
A current hypothesis for the pathology of Alzheimer's disease (AD) proposes that amyloid-beta (A[bet...
AbstractAlzheimer's disease (AD) is associated with impaired glutamate clearance and depressed Na+/K...
Astrocyte dysfunction emerges early in Alzheimer's disease (AD) and may contribute to its pathology ...
Altered neuronal excitability is emerging as an important feature in Alzheimer's disease (AD). Kv2.1...
Amyloid beta (Aβ) accumulation plays an important role in the pathogenesis of Alzheimer's disease (...
Previous studies have shown that amyloid $\beta$-peptide (A$\beta$P), a normally secreted protein fo...
Alzheimer’s disease (AD) is a progressive and irreversible brain disorder which results in memory lo...
ABSTRACT: Tau is a microtubule associated protein implicated in the pathogenesis of several neurodeg...
The aim of the present study was to investigate whether K(V)3.4 channel subunits are involved in neu...
Alzheimer’s disease (AD) is the most common neurodegenerative disorder and the first cause of dement...
Aβ deposition is a pathological hallmark of Alzheimer's disease (AD). Besides the full-length amyloi...
Alzheimer’s disease (AD) is a neurodegenerative disorder characterized by the progressive deteriorat...
The prevailing hypothesis for pathology of Alzheimer's disease (AD) proposes that amyloid-beta (A[Be...
Alzheimer’s disease is characterized by a marked dysregulation of intracellular Ca2+ homeostasis. In...
Deposition of beta-amyloid peptide (A beta) in senile plaques is a hallmark of Alzheimer disease neu...
A current hypothesis for the pathology of Alzheimer's disease (AD) proposes that amyloid-beta (A[bet...
AbstractAlzheimer's disease (AD) is associated with impaired glutamate clearance and depressed Na+/K...
Astrocyte dysfunction emerges early in Alzheimer's disease (AD) and may contribute to its pathology ...